Evaluation of RGD-Targeted Albumin Carriers for Specific Delivery of Auristatin E to Tumor Blood VesselsKai Temming, Robbert J. Kok, Klaas Poelstra et al.|Bioconjugate Chemistry|2006Cited by 52
Delivery of the p38 MAPkinase Inhibitor SB202190 to Angiogenic Endothelial Cells: Development of Novel RGD-Equipped and PEGylated Drug−Albumin Conjugates Using Platinum(II)-Based Drug Linker TechnologyKai Temming, Robbert J. Kok, M. Lacombe et al.|Bioconjugate Chemistry|2006Cited by 46